(1 reference)-
- 抗原 See all MEF2C 抗体
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
抗原表位
- pSer222
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This MEF2C antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 交叉反应
- 人
- 预测反应
- bovine, chicken, guinea pig, mouse, non-human primate, rat, sheep
- 纯化方法
- Antigen Affinity Purified from Pooled Serum
- 免疫原
- Synthetic phospho-peptide corresponding to amino acid residues surrounding Ser222 conjugated to KLH
- Top Product
- Discover our top product MEF2C Primary Antibody
-
anti-Myocyte Enhancer Factor 2C (MEF2C) (AA 1-125) antibody
MEF2C 适用: 人 WB, ELISA, IHC, FACS 宿主: 小鼠 Monoclonal 6H2G2 unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) antibodyMEF2C 适用: 人 WB, IHC, IF, IHC (p), ICC, IHC (fro), IP 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) antibodyMEF2C 适用: 人, 小鼠, 大鼠 IHC 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (AA 170-380) antibodyMEF2C 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (AA 365-394) antibodyMEF2C 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) antibodyMEF2C 适用: 人, 小鼠, 大鼠 IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (Ser396) antibodyMEF2C 适用: 人 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (Ser59) antibodyMEF2C 适用: 人 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (Ser396) antibodyMEF2C 适用: 人 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Myocyte Enhancer Factor 2C (MEF2C) (AA 170-380) antibodyMEF2C 适用: 人 WB, ELISA, IHC 宿主: 兔 Polyclonal unconjugated
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- 100 μL in 10 mM HEPES ( pH 7.5), 150 mM NaCl, 100 μg per ml BSA and 50 % glycerol.
- 储存条件
- -20 °C
-
-
: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
: "MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia. ..." in: Cancer discovery, Vol. 8, Issue 4, pp. 478-497, (2019) (PubMed).
-
- 抗原
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
- 别名
- MEF2C (MEF2C 产品)
- 别名
- MEF2C antibody, XMEF2C antibody, si:ch211-202e12.2 antibody, C5DELq14.3 antibody, DEL5q14.3 antibody, 5430401D19Rik antibody, 9930028G15Rik antibody, AV011172 antibody, Mef2 antibody, RGD1563119 antibody, id:ibd5026 antibody, mef2c antibody, wu:fc05b06 antibody, zgc:64184 antibody, zgc:85726 antibody, myocyte enhancer factor 2C antibody, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) antibody, myocyte enhancer factor 2cb antibody, MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C) L homeolog antibody, myocyte enhancer factor 2ca antibody, MEF2C antibody, mef2c antibody, mef2cb antibody, mef2c.L antibody, Mef2c antibody, mef2ca antibody
- 分子量
- '51 kDa
- 基因ID
- 4208
- UniProt
- Q06413
- 途径
- Neurotrophin Signaling Pathway, Activation of Innate immune Response, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Chromatin Binding, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, Toll-Like Receptors Cascades, BCR Signaling
-
You are here:
